Curt oltmans
CLO Fulcrum Therapeutics
Seminars
Wednesday 5th August 2026
Roundtable Discussion: Translating Policy Signals into Board-Level Strategy, Risk Framing & Asset Decision-Making
12:00 pm
- Reframe pricing reform and policy shifts as strategic drivers of valuation by translating
- evolving signals into clear board-level scenariosEmbed policy awareness into asset strategy by shaping indication sequencing, lifecycle planning, and capital allocation early
- Strengthen enterprise resilience by aligning legal, government affairs, and executive leadership on proactive risk and value protection
Wednesday 5th August 2026
Panel Discussion: Stabilizing Development Momentum to Preserve Market Confidence During Regulatory Volatility
9:15 am
- Maintain investor and partner confidence by aligning regulatory pivots with disciplined communications
- Protect timelines and budgets by responding decisively to CRLs, endpoint shifts, and evolving agency expectations
- Strengthen resilience by leveraging patient advocacy, public affairs, and cross-functional escalation pathways during periods of agency uncertainty
